Exome-sequencing identifies novel rheumatoid arthritis-susceptible variants in the BTNL2
SupplementaryInformation
Supplementary Figure 1 Flowchart of this study.
Supplementary Figure 2 Amino acid changes caused by the 3 BTNL2 SNPs in humans andsome other mammalian species.
Supplementary Figure 3 LD plot of the region from NOTCH4 to DRB1 displayed in r2 using the Haploview program. LD blocks were created by the GAB algorithm. The region was divided into 3 LD blocks except for rs2076530 in the exon 5 of BTML2 and DRB1*04:05.
Supplementary Table 1 PCR primers used in this study
Supplementary Table 2 Filtering of SNV detected by exome sequencing
Supplementary Table 3 Top 30 Genes in the difference of average number of SNV
Supplementary Table 4 The difference of average number of SNV in the RA-susceptible genes
Supplementary Table 5 Comparison of the number of BTNL2 SNVs in the patients and controls with respect to HLA-DRB1 genotypes
1
Supplementary Figure 1 Flowchart of this study.
Supplementary Figure 2 Amino acid changes caused by the 3 BTNL2 SNPs in humans andsome other mammalian species.
Supplementary Figure 3 LD plot of the region from NOTCH4 to DRB1 displayed in r2 using the Haploview program. LD blocks were created by the GAB algorithm. The region was divided into 3 LD blocks except for rs2076530 in the exon 5 of BTML2 and DRB1*04:05.
Supplementary Table 1 PCR primers used in this study
Target genePrimer name SequenceSNP ID
exonin amplicon
BTNL2
exon 6BNe6F5’-TCCAAACCTGAAGGAACATAAGGA-3’
BNe6R5’-ATGCTCCAGCCAGCCTCATC-3’
rs28362675
rs41521946
rs28362677
rs28362678
exon 5BNe5F5’-GACCTTCCCAGCCCATCCTC-3’
BNe5R5’-TCAGAGAAATTGTCCAGGAACTAGCA-3’
rs2076530
rs41441651
rs41417449
rs34423804
rs41355746
exon 3BNe3F5’-CTCCTGAACTCCGGCCACCT-3’
BNe3R5’-CGAGGTGCTATGGTGCAGTCC-3’
rs28362680
rs2076523
rs78587369
NOTCH4
intron 4/NCF5’-CAGCTTCGGGACTTCTGTTCAGC-3’
exon 4NCR5’-GACAGGGTCATGGATCAGCTGTG-3’
rs2071284
rs2071283
rs2071282
rs2071281
rs415929
Supplementary Table 2 Filtering of SNV detected by exome sequencing
Filtering StepCaseDisease control
Rheumatoid arthritisnon-autoimmune disease
(19 cases)(44 controls)
Total number of SNVs366,9481,036,369
Number of variants57,22597,452
Exclusion of synonymous SNVs31,53761,692
Exclusion of segmental duplications26,80655,135
Average supporting read ≥ 820,27535,997
Average SNP quality ≥ 10018,66034,313
Supplementary Table 3 Top 30 Genes in the difference of average number of SNV
GeneCytogeneticDifference inNumber of SNVb
locationaverage number of SNVa
BTNL26p21.326.3 16
CDC2717q21.326.0 14
PRRC2A6p21.333.7 9
FAM104BXp11.213.4 9
CTBP210q26.133.0 13
OR12D26p22.2-p21.312.9 7
ZNF8319q13.32.8 13
MUC216p21.322.5 19
VARS26p21.332.0 9
CCHCR16p21.331.9 14
UBD6p22.11.8 6
C6orf106p21.31.7 10
LCN159q34.31.7 3
NOTCH46p21.321.510
OR10C16p22.11.4 7
C6orf476p21.31.3 2
PRSS27q351.3 7
HSPA1L6p21.331.3 2
OR2J36p22.11.3 4
KIAA168319p13.11.3 10
MOG6p22.11.2 2
CDSN6p21.331.1 2
WDR466p21.31.1 2
EFCAB4B12p13.321.1 5
MCCD16p21.331.1 2
CDC42BPA1q42.131.0 7
MYPN10q21.31.0 6
KDM4DL11q211.0 2
PRG311q12.11.0 3
KIAA126717q21.311.0 2
a The difference in the average number of SNVs in each gene between 19 cases and 44 controls.
b The number of SNV in cases.
Supplementary Table 4 The difference of average number of SNV in the RA-susceptible genes a
GeneCytogeneticaverage number of SNV
locationRAbControlc
C6orf106p21.31.7 0.0
PADI41p36.131.7 1.6
NOTCH46p21.31.5 0.0
AFF32q11.2-q121.2 1.3
LONRF22q11.21.1 1.5
PTPN221p13.21.1 1.0
ZNF77415q26.11.1 1.1
SH2B312q241.0 1.0
C59q34.10.9 0.9
ARHGEF33p14.30.7 0.3
C1QTNF622q13.10.7 0.7
CSF25q31.10.6 0.5
CTLA42q330.6 0.6
GSDMB17q120.6 0.8
TNFRSF141p36.320.6 0.6
MMEL11p360.4 0.5
AIRE21q22.30.3 0.4
PRKCQ10p150.3 0.4
TMEM172p150.3 0.3
ANKRD555q11.20.3 0.2
DSCAM21q22.20.3 0.4
ZPBP217q120.3 0.2
KIAA11094q270.2 0.4
ARAP111q13.40.2 0.3
IL6ST5q11.20.2 0.2
PRKCH14q23.10.2 0.3
PLD414q32.330.1 0.1
FOXF116q240.1 0.1
IL2RB22q13.10.1 0.3
PIP4K2C12q13.30.1 0.1
TNFAIP36q230.1 0.1
ANAPC44p15.20.0 0.0
ARID5B10q21.20.0 0.0
CD4020q12-q13.20.0 0.0
CD836p230.0 0.0
IL24q26-q270.0 0.0
IRF816q24.10.0 0.0
PDE2A11q13.40.0 0.1
PHF199q33.20.0 0.0
ANXA34q21.21-d-
APOM6p21.33--
B3GNT22p15--
BATF14q24.3--
BDP1P18q23--
BLK8p23-p22--
C21orf13021q22.2--
C4orf524p15.2--
C5orf305q21.1--
C9orf1449p13.2--
C9orf144B9p12--
CCL219p13--
CCR66q27--
CD2471q24.2--
CDK67q21-q22--
DKFZp667F071110p15.1--
ETS111q23.3--
FAM107A3p21.1--
FAM167A8p23-p22--
FLI111q24.1-q24.3--
GCH114q22.1-q22.2--
GEMIN8P115q23--
HCP5P126p21.3--
IKZF317q21--
IL214q26-q27--
IL2RA10p15-p14--
IRF57q32--
JDP214q24.3--
KIF31p36.12--
KIF5A12q13.13--
KRT18P392q33.2--
MICA6p21.33--
NFKBIE6p21.1--
NR6p21.32--
OLIG36q23.3--
P4HA25q31--
PFKL21q22.3--
POU3F11p34.1--
PRKCB16p11.2--
PRKCB116p11.2--
PTPN218p11.3-p11.2--
PXK3p14.3--
RBPJ4p15.2--
REL2p13-p12--
RNF1826p23--
RPLP115q22--
RPS12P32p16.1--
RPS14P107q32.3--
RPS15AP227q32.3--
RPS2P141p13--
RRAGC1p34--
RSBN11p13.2--
SALL318q23--
SPRED22p14--
STAT42q32.2-q32.3--
TNPO37q32.1--
TRAF19q33-q34--
TRHDE12q15-q21--
UBASH3A21q22.3--
a Genes listed in “A Catalog of Published Genome-Wide Association Studies”(
b 19 RA cases
c 44 disease control
dNo non-synonymous SNV was observed in exome sequencing of 19 RA followed by filtering in this study.“0.0” in the column of the average number of SNV indicates 0 < N < 0.1.
Supplementary Table 5 Comparison of the number of BTNL2 SNVs in the patients and controls with respect to HLA-DRB1 genotypes
GenotypeNumber of cases Average num. of BTNL2 SNV
RACont.RACont.
DRB1*04:05, 09:01361312.0 11.5
DRB1*04:05, 04:0524612.0 10.8
DRB1*04:05, 15:0222812.0 11.9
DRB1*09:01, 09:011872.0 0.0
DRB1*09:01, 15:02122011.7 12.0
DRB1*01:01, 04:0511711.2 11.7
DRB1*01:01, 09:011174.1 4.4
DRB1*08:03, 09:0110131.9 2.1
DRB1*01:01, 15:029611.8 11.8
DRB1*04:05, 08:0391211.8 11.1
DRB1*04:05, 04:0681110.8 10.2
DRB1*04:05, 13:028812.0 7.8
DRB1*08:03, 15:01662.0 2.0
DRB1*09:01, 15:01691.0 0.0
DRB1*08:03, 15:025612.0 11.8
The overall average number of BTNL2 SNV as follows: Case (n = 411), 7.8; Control (n = 420), 5.8.
1